L1045
LY-354740 hydrate
≥98% (HPLC)
Sinónimos:
(1S,2S,5R,6S)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxy lic acid, Eglumegad, Eglumetad, LY-354740
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
| Talla/SKU | Disponibilidad | Precio |
|---|---|---|
5 mg | Comprobar disponibilidad del carrito | $167.00 |
Acerca de este artículo
Fórmula empírica (notación de Hill):
C8H11NO4 · xH2O
Peso molecular:
185.18 (anhydrous basis)
UNSPSC Code:
12352209
NACRES:
NA.77
eCl@ss:
32160406
Assay:
≥98% (HPLC)
Form:
solid
$167.00
Comprobar disponibilidad del carrito
Las suscripciones no están disponibles actualmente.
Naves cada 4 semanas
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleQuality Segment
assay
≥98% (HPLC)
form
solid
solubility
deionized water: 8 mg/mL
originator
Eli Lilly
storage temp.
room temp
Application
LY-354740 hydrate has been used as a metabotropic glutamate receptor group II/III agonist to study its behavioral effectsof electric shock on Gammarus fossarum.
Biochem/physiol Actions
LY-354740 is a highly selective and potent agonist of group II mGlu (metabotropic glutamate) receptors.
LY-354740 is a highly selective and potent agonist of group II mGlu (metabotropic glutamate) receptors. It displays antianxiety and antiaddictive activity in vivo. It?s orally and systemically active. It is anxiolytic and inhibits symptoms of morphine withdrawal in morphine-dependent mice.
Features and Benefits
This compound is a featured product for Neuroscience research. Click here to discover more featured Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
This compound is featured on the Glutamate Receptors (G Protein Family) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Eli Lilly. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
1 of 1
Este artículo | |||
|---|---|---|---|
| description ≥98% (HPLC) | description ≥98% (HPLC) | description ≥98% (HPLC) | description ≥98% (HPLC) |
| form solid | form solid | form powder | form powder |
| assay ≥98% (HPLC) | assay ≥98% (HPLC) | assay ≥98% (HPLC) | assay ≥98% (HPLC) |
| Quality Level 100 | Quality Level 100 | Quality Level 100 | Quality Level 100 |
| storage temp. room temp | storage temp. 2-8°C | storage temp. 2-8°C | storage temp. room temp |
| solubility deionized water: 8 mg/mL | solubility deionized water: >10 mg/mL | solubility H2O: 2 mg/mL, clear (warmed) | solubility H2O: 20 mg/mL, clear |
| originator Eli Lilly | originator - | originator - | originator - |
Palabra de advertencia
Warning
Códigos de peligro
Indicaciones de precaución
Hazard Classifications
Acute Tox. 4 Oral
Clase de almacenamiento
11 - Combustible Solids
¿Qué está pasando?
WGK 3
Punto de inflamación (°F)
Not applicable
Punto de inflamación (°C)
Not applicable
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.